Novabay Pharmaceuticals Inc.
13F holders, Q4 2025 (December 31)26holders +12
14new positions
2sold out
$5.64avg. 13F price*
At the end of Q4 2025, 26 institutions reported holding Novabay Pharmaceuticals Inc. in their 13F filings, up 12 from Q3 2025. 14 opened new positions and 2 sold out. The largest holders were BlackRock, Inc. ($10.3M), Vanguard Group Inc. ($10.3M) and Geode Capital Management, LLC ($7.1M).
- Company
- Novabay Pharmaceuticals Inc.
- CUSIP
- 66987P409
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $14.9M |
| Exits | 2 | $39K |
All 13F filers, Q3 2025 → Q4 2025: 5,898,053 shares bought and 30,249 shares sold, net +5,867,804 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| BlackRock, Inc. | 0.00% | New | 1,830,728 | $10.3M |
| Vanguard Group Inc. | 0.00% | Add +2065.1% | 1,829,223 | $10.3M |
| Geode Capital Management, LLC | 0.00% | Add +2331.7% | 1,257,705 | $7.1M |
| State Street Corp. | 0.00% | Add +970.5% | 313,703 | $1.8M |
| Northern Trust Corp. | 0.00% | New | 273,788 | $1.5M |
| Goldman Sachs Group Inc. | 0.00% | New | 104,341 | $588K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 93,261 | $526K |
| Jane Street Group, LLC | 0.00% | New | 70,070 | $395K |
| Susquehanna International Group, LLP | 0.00% | New | 46,744 | $264K |
| C2C Wealth Management, LLC | 0.21% | New | 45,000 | $254K |
| Qube Research & Technologies Ltd | 0.00% | New | 40,826 | $230K |
| UBS Group AG | 0.00% | New | 33,598 | $189K |
| Apollon Wealth Management, LLC | 0.00% | No change | 27,561 | $155K |
| Bank of New York Mellon Corp | 0.00% | New | 25,799 | $146K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 21,200 | $120K |
| Morgan Stanley | 0.00% | Add +684200.0% | 20,529 | $116K |
| ExodusPoint Capital Management, LP | 0.00% | New | 20,160 | $114K |
| Compound Planning, Inc. | 0.00% | New | 16,821 | $95K |
| Victory Capital Management Inc. | 0.00% | New | 14,354 | $81K |
| Citigroup Inc. | 0.00% | Add +100.4% | 4,676 | $26K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +214.8% | 2,984 | $17K |
| Bank of America Corp. | 0.00% | Add +2393.8% | 1,197 | $7K |
| Royal Bank of Canada | 0.00% | Add +19000.0% | 191 | $1K |
| Nvwm, LLC | 0.00% | No change | 3 | $17 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1 | $6 |
| Addison Advisors LLC | 0.00% | No change | 1 | $6 |
"% of holder's portfolio" is NOVABAY PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Novabay Pharmaceuticals Inc. the manager owns.